First-Ever Publicly Traded Cannabis Company in U.S. to Sponsor Money Show Dallas’ Welcome Reception; RSHO™ Parent Advocate Penny Howard to Speak About CBD Hemp Oil
San Diego, CA – October 19, 2016 – Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that at The Money Show Dallas, which the Company is sponsoring, Medical Marijuana, Inc. Chief Executive Officer Dr. Stuart Titus will speak to investors about current global cannabis industry trends and cannabis investment opportunities. The Money Show Dallas, taking place from Oct. 19-21 at the Hyatt Regency in Dallas, is a conference for investors and traders in search of opportunities for diversification and profit across the globe.
“We’re in the midst of a global cannabis revolution and I’m honored to have been invited to speak to investors at the Money Show Dallas about reasons to get involved in this fast-growing industry with limitless opportunities,” said Dr. Titus. “The entire cannabis industry, including both marijuana and hemp, offers an incredible growth opportunity for astute investors and is helping people who suffer with debilitating conditions across the globe.”
Dr. Titus will present, “Cannabis Investing 101” on Thursday, October 20, at 5:00 p.m. Representatives from Medical Marijuana, Inc.’s Investor Relations team will also be available at the Company’s booth in the Grand Hall for sit-down meetings and questions.
Medical Marijuana, Inc. is also sponsoring the Money Show Dallas Welcoming Reception, being held on Thursday, Oct. 20 beginning at 8:30 a.m. In addition, Dallas mom and RSHO™ advocate Penny Howard will present “Mothers, Social Media, and Emerging Markets,” at the MoneyShow on Friday, Oct. 21 at 10:30 a.m. Howard will discuss how sharing her late daughter Harper’s story on Facebook helped a family in Brazil and led to a series of challenges to marijuana policies in the country.
For more information on the Money Show Dallas, visit: http://www.dallasmoneyshow.com and for Medical Marijuana, Inc. visit medicalmarijuanainc.com.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
Public Relations Contact:
Chief Executive Officer
Corporate Business Contact:
Nicholas R. Massalas
Director of Business Development
Medical Marijuana, Inc.
OTC Symbol: MJNA
Toll Free: 888-OTC- MJNA (888-682- 6562)
Investor Relations Contact:
Toll Free: (877) 964.6463
Office/Direct: (858) 264-6500
Email: [email protected]